Inhibition of the multidrug resistance efflux pump

Area of Science:

• Biochemistry
• Pharmacology
• Cancer Biology

Background:

• Multidrug resistance (MDR) in cancer is mediated by ATP-dependent efflux pumps in the plasma membrane.
• These pumps reduce intracellular drug concentrations to sub-cytotoxic levels, causing treatment failure.

Purpose of the Study:

• To review methods for estimating the reversal potency of MDR efflux pump inhibitors.
• To present information on the transport characteristics of reversal agents.
• To derive and analyze rate equations for drug efflux and inhibition mechanisms.

Main Methods:

• Review of various methods for estimating reversal potency.
• Analysis of transport characteristics of reversal agents.
• Derivation of rate equations for ATP-dependent drug efflux and pump inhibition (competitive and noncompetitive).
• Development of a method to differentiate between competitive and noncompetitive inhibition.

Main Results:

• Inhibition of MDR efflux pumps by reversal agents can restore drug sensitivity.
• The inhibition of these pumps is stereospecific, as demonstrated with cinchonine.
• Mathematical models for efflux and inhibition were developed and analyzed.
• A novel method was presented to distinguish between competitive and noncompetitive inhibition mechanisms.

Conclusions:

• Fundamental studies on MDR efflux pump inhibition are crucial for designing effective clinical reversal strategies.
• Understanding the kinetics and stereospecificity of reversal agents can guide the development of novel cancer therapies.
• The derived models and discrimination method offer valuable tools for evaluating potential MDR reversal agents.